MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.

Details

Daily high

$2.54

Daily low

$2.33

Price at open

$2.40

52 Week High

$15.75

52 Week Low

$2.12

Market cap

6.9M

Dividend yield

0.00%

Volume

31,176

Avg. volume

46,709

P/E ratio

-.21

Moleculin Biotech News